Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation-Reference-Cited by-同舟云学术

Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation

Published:2016-01-22 Issue:4 Volume:95 Page:557-562
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Schwaab Juliana,Jawhar Mohamad,Naumann Nicole,Schmitt-Graeff Annette,Fabarius Alice,Horny Hans-Peter,Cross Nicholas C. P.,Hofmann Wolf-Karsten,Reiter Andreas,Metzgeroth Georgia

Funder

José Carreras Leukämie-Stiftung (DE)

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-016-2598-x.pdf

Reference14 articles.

1. Metzgeroth G, Schwaab J, Gosenca D, Fabarius A, Haferlach C, Hochhaus A, Cross NC, Hofmann WK, Reiter A (2013) Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase. Leukemia 27(11):2254–2256

2. Valent P, Klion AD, Rosenwasser LJ, Arock M, Bochner BS, Butterfield JH, Gotlib J, Haferlach T, Hellmann A, Horny HP, Leiferman KM, Metzgeroth G, Matsumoto K, Reiter A, Roufosse F, Rothenberg ME, Simon HU, Sotlar K, Vandenberghe P, Weller PF, Gleich GJ (2012) ICON: eosinophil disorders. The World Allergy Organization journal 5(12):174–181

3. Walz C, Score J, Mix J, Cilloni D, Roche-Lestienne C, Yeh RF, Wiemels JL, Ottaviani E, Erben P, Hochhaus A, Baccarani M, Grimwade D, Preudhomme C, Apperley J, Martinelli G, Saglio G, Cross NC, Reiter A (2009) The molecular anatomy of the FIP1L1-PDGFRA fusion gene. Leukemia 23(2):271–278

4. Walz C, Cross NC, Van Etten RA, Reiter A (2008) Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders. Leukemia 22(7):1320–1334

5. Walz C, Metzgeroth G, Haferlach C, Schmitt-Graeff A, Fabarius A, Hagen V, Prummer O, Rauh S, Hehlmann R, Hochhaus A, Cross NC, Reiter A (2007) Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene. Haematologica 92(2):163–169

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals;Current Hematologic Malignancy Reports;2024-07-22

2. Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis;Cancers;2024-03-31

3. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-03-29

4. Acute Myeloid Leukaemia With Translocation (8;21) Masquerading as Peripheral Blood Eosinophilia Having Dysplastic Features: A Diagnostic Challenge;Cureus;2023-01-17

5. Das idiopathische hypereosinophile Syndrom - Diagnostik und Therapie;Allergo Journal;2022-10-31